TABLE 2.
Univariate and multivariate Cox regression analyses of clinical characteristics and risk score in GSE62254.
Univariate Cox | Multivariate Cox | ||||
regression |
regression |
||||
Characteristics | Number | Hazard Ratio (95%CI) | p-value | Hazard Ratio (95%CI) | p-value |
Age | 298 | 1.011 (0.996–1.026) | 0.157 | 1.028 (1.012–1.044) | 0.001 |
Gender | |||||
Male/Female | 197/101 | 0.917 (0.656–1.282) | 0.611 | ||
Tumor stage | |||||
II/I | 96/30 | 1.955 (0.759–5.034) | 0.165 | 1.678 (0.649–4.338) | 0.285 |
III/I | 95/30 | 4.064 (1.623–10.176) | 0.003 | 2.669 (1.030–6.920) | 0.043 |
IV/I | 77/30 | 9.737 (3.907–24.265) | <0.001 | 4.837 (1.755–13.328) | 0.002 |
T | |||||
T3-4/T1-2 | 112/186 | 2.365 (1.719–3.255) | <0.001 | ||
N | |||||
N1-3/N0 | 260/38 | 2.847 (1.450–5.589) | 0.002 | ||
M | |||||
M1/M0 | 27/271 | 3.806 (2.460–5.888) | <0.001 | ||
Number of lymph nodes examined | 298 | 0.987 (0.976–0.998) | 0.023 | ||
number of positive lymph nodes | 298 | 1.072 (1.056–1.087) | <0.001 | ||
LNR | 298 | 25.430 (13.312–48.578) | <0.001 | 7.030 (2.803–17.631) | <0.001 |
Risk score | 298 | 5.205 (2.750–9.853) | <0.001 | 4.059 (2.097–7.855) | <0.001 |